Dr. Gerald Diaz @GeraldMD
39.7M 14.2K 7.5K
Board Certified Internal Medicine Hospitalist, GrepMed Editor in Chief 🇵🇭 🇺🇸 - Sign up for an account to like, bookmark and upload images to contribute to our community platform. Follow us on IG: https://www.instagram.com/grepmed/ | Twitter: https://twitter.com/grepmeded/
Contributor Ranks
Latest Searches
10 results
pharmacology dm2 treatment criticalcare diagnosis hivaids idsa infections mycobacterium opportunistic prevention antidiabetic aviumcomplex bisphosphonates comparison decisionaid delirium diabetic dpp4 eudka
Profiles of Antidiabetic Medications - AACE 2018 #Antidiabetic #Medications #Profiles #SideEffects #Table #DecisionAid #Orals #DM2 #Diabetes
of Antidiabetic Medications ... #SideEffects #Table ... DecisionAid #Orals #DM2 #Diabetes ... #Endocrinology ... #Pharmacology #Management
Diabetes Medications Summary Table Insulin Lifestyle modifications Metformin Sulfonylureas GLP-1 receptor agonists - ↓ major adverse CV events TZDs DPP-4 inhibitors SGLT2 inhibitors -
Diabetes Medications ... Summary Table ... #medications #table ... #comparison #management ... #endocrinology
Bisphosphonates for Osteoporosis Treatment or Prevention Bisphosphonates are common medications used in the treatment and prevention
Bisphosphonates are common medications ... There are 4 drugs ... are a variety of dosing ... #Pharmacology #Endocrinology ... #Osteoporosis #Management
DPP4 Inhibitors - Normal and Renal Dosing Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
Normal and Renal Dosing ... This drug class ... #Pharmacology #Management ... #Diabetes #DM2 ... #Endocrinology
Euglycemic Diabetic Ketoacidosis (EuDKA) SGLT2 Inhibitors Increasing Indications Significant Adverse Drug Effects Definition of EuDKA • Metabolic acidosis with pH
Euglycemic Diabetic ... Inhibitors Increasing Indications ... Significant Adverse Drug ... EuDKA #diagnosis #management ... #endocrinology
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist Dosing: 3 mg daily x 30 days, then 7 mg
GLP-1 Agonist Dosing ... to remain stable ... patients to take meds ... #semaglutide #Diabetes ... #Pharmacology #Endocrinology
Pancreatitis management checklist Evaluation to guide etiology & management - RUQ ultrasound - Calcium
checklist Evaluation ... - Review of medication ... potentially causative drugs ... limit them as able ... #Pancreatitis #Checklist
Checklist for Treatment of Delirium in the ICU Remove causative factors - Exclude hypoglycemia if
Checklist for Treatment ... - Review the medication ... c deliriogenic meds ... #Delirium #Checklist ... #Management #Treatment
IDSA Recommendations for Preventing and Treating Disseminated Mycobacterium Avium Complex in HIV-AIDS Preventing 1st Episode of Disseminated
Prophylaxis): Indications ... necessary based on drug-drug ... please refer to Table ... 5 for dosing recommendation ... Prevention #Treatment #management
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS Treating LTBI (to prevent TB disease) Indications:
prevent TB disease) Indications ... Please refer to the table ... dosing recommendations ... Guidelines for dosing ... Prevention #Treatment #management
empty